Palexia SR

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 25 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Slightly brownish-orange film-coated oblong shaped tablets with Grunenthal logo engraving on one side and H9 on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 pack
100 pack
14 pack
20 pack
28 pack
30 pack
40 pack
50 pack
56 pack
60 pack
7 pack
90 pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
White, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H1' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Is this medicine subsidised ?

(PBS)

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 100 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale yellow, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H2' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Is this medicine subsidised ?

(PBS)

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 150 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale pink, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H3' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Is this medicine subsidised ?

(PBS)

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 200 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Pale orange, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H4' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Is this medicine subsidised ?

(PBS)

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Brand name

(ARTG)

: PALEXIA SR tapentadol (as hydrochloride) 250 mg sustained release tablet blister pack

Download the Consumer Medicine Information Leaflet

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

This medicine is classified as an opioid. The use of opioids comes with side effects including life-threatening breathing problems and the risk of abuse, misuse, and addiction. They should be taken with care. To find out more about opioid medicines and alternatives for managing pain, visit the healthdirect opioid medicines and pain hub.

What this medicine is used for

(ARTG)

PALEXIA SR is indicated for the management of severe pain where: other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. PALEXIA SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. PALEXIA SR is not indicated as an as-needed (PRN) analgesia.

How to use this medicine

(ARTG)

This medicine contains one component only.

Component :

Tablet, modified release
Oral
Brownish-red, film-coated, oblong-shaped tablets, engraved with Grunenthal logo on one side and 'H5' on the other side

Storage conditions

(ARTG)

Store below 30 degrees Celsius
Shelf lifetime is 3 Years.

Do I need a prescription ?

(ARTG)

These medicines require authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.

10 tablet pack
100 tablet pack
14 tablets pack
20 tablet pack
28 tablets pack
30 tablet pack
40 tablet pack
50 tablet pack
56 tablets pack
60 tablet pack
7 tablets pack
90 tablet pack

Is this medicine subsidised ?

(PBS)

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy ?

(AHT)

For the active ingredient tapentadol

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

(ARTG)

Download the Consumer Medicine Information Leaflet

What this medicine is used for

(ARTG)

How to use this medicine

(ARTG)

Component :

Storage conditions

(ARTG)

Do I need a prescription ?

(ARTG)

What is the medicines and poisons schedule?

Pregnant or planning a pregnancy ?

(AHT)

Reporting side effects

(ARTG)

Download the Consumer Medicine Information Leaflet

What this medicine is used for

(ARTG)

How to use this medicine

(ARTG)

Component :

Storage conditions

(ARTG)

Do I need a prescription ?

(ARTG)

What is the medicines and poisons schedule?

Pregnant or planning a pregnancy ?

(AHT)

Reporting side effects

(ARTG)

Download the Consumer Medicine Information Leaflet

What this medicine is used for

(ARTG)

How to use this medicine

(ARTG)

Component :

Storage conditions

(ARTG)

Do I need a prescription ?

(ARTG)

What is the medicines and poisons schedule?

Pregnant or planning a pregnancy ?

(AHT)

Reporting side effects

(ARTG)

Download the Consumer Medicine Information Leaflet

What this medicine is used for

(ARTG)

How to use this medicine

(ARTG)

Component :

Storage conditions

(ARTG)

Do I need a prescription ?

(ARTG)

What is the medicines and poisons schedule?

Pregnant or planning a pregnancy ?

(AHT)

Reporting side effects

(ARTG)

Download the Consumer Medicine Information Leaflet

What this medicine is used for

(ARTG)

How to use this medicine

(ARTG)

Component :

Storage conditions

(ARTG)

Do I need a prescription ?

(ARTG)

What is the medicines and poisons schedule?

Pregnant or planning a pregnancy ?

(AHT)

Reporting side effects

(ARTG)

Download the Consumer Medicine Information Leaflet

What this medicine is used for

(ARTG)

How to use this medicine